Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 1.10.2024MEDOCHEMIE Ltd. (MOE)2834BMANTOMED 10 mg (tbl flm 56x10 mg (blis.PVC/PE/PVDC/Al))30.9.2024O
 1.10.2024MEDOCHEMIE Ltd. (MOE)2849BMANTOMED 20 mg (tbl flm 28x20 mg (blis.PVC/PE/PVDC/Al))30.9.2024O
 1.10.2024MEDOCHEMIE Ltd. (MOE)33199MEDOFLUCON 50 mg (cps dur 100x50 mg (blis.PVC/Al))30.9.2024R
 1.10.2024MEDOCHEMIE Ltd. (MOE)3671CMEDOCLAV 400 mg/5 ml + 57 mg/5 ml prášok na perorálnu suspenziu (plu por 1x70 ml (fľ.skl.hnedá+dáv.striek.))30.9.2024O
 1.10.2024MEDOCHEMIE Ltd. (MOE)36925ALMIRAL GEL (gel 1x50 g (tuba Al))30.9.2024R
 1.10.2024MEDOCHEMIE Ltd. (MOE)39266MEDORISPER 1 mg (tbl flm 50x1 mg (blis.PVC/PE/PVDC/Al))30.9.2024R
 1.10.2024MEDOCHEMIE Ltd. (MOE)39274MEDORISPER 2 mg (tbl flm 50x2 mg (blis.PVC/PE/PVDC/Al))30.9.2024R
 1.10.2024MEDOCHEMIE Ltd. (MOE)39638ALMIRAL GEL (gel 1x100 g (tuba Al))30.9.2024R
 1.10.2024MEDOCHEMIE Ltd. (MOE)40200KLERIMED 250 mg (tbl flm 14x250 mg (blis.PVC/PVDC/Al))30.9.2024O
 1.10.2024MEDOCHEMIE Ltd. (MOE)4031CDinarex 1,5 mg/ml sirup (sir 1x200 ml (fľ.skl.hnedá s Al viečkom+odmer.lyž.))30.9.2024O
 1.10.2024MEDOCHEMIE Ltd. (MOE)46235MEDOTRIGIN 25 mg (tbl 30x25 mg)30.9.2024O
 1.10.2024MEDOCHEMIE Ltd. (MOE)46239MEDOTRIGIN 50 mg (tbl 30x50 mg (blis.PVC/Al))30.9.2024O
 1.10.2024MEDOCHEMIE Ltd. (MOE)46243MEDOTRIGIN 100 mg (tbl 30x100 mg)30.9.2024R
 1.10.2024MEDOCHEMIE Ltd. (MOE)46245MEDOTRIGIN 100 mg (tbl 100x100 mg)30.9.2024R
 1.10.2024MEDOCHEMIE Ltd. (MOE)59193BETAC (tbl flm 100x20 mg (blister PVC/Al))30.9.2024O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To